pindolol has been researched along with Coronary Disease in 93 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "10 patients (6 females and 4 males with an average age of 75 years) with stable angina pectoris were treated transdermally with mepindolol in a balanced, randomized, controlled, crossover study to compare the anti-ischemic effects of 12-hour overnight, and 24-hour applications." | 9.07 | Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application. ( Bonelli, J; Gazo, F; Kirsch, P; Liedtke, RK, 1991) |
| "A new transdermal beta-blocker containing system (Mepindolol BIO TSD) was compared in a placebo controlled cross over trial with a transdermal nitrate system in 14 patients suffering from coronary heart disease with stable angina pectoris." | 9.06 | [Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate]. ( Bonelli, J; Falkner, C; Gazo, F; Liedtke, RK, 1990) |
| "A new transdermal system (BIO TSD) containing the beta-adrenergic blocker mepindolol was assessed in a placebo controlled clinical trial in 12 patients with coronary heart disease." | 9.06 | [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris]. ( Bonelli, J; Gazo, F; Liedtke, RK, 1989) |
| "In a randomized, controlled study we found a significant decrease in pressure-rate (double) product and an improvement in exercise tolerance in patients with angina pectoris treated with pindolol." | 9.05 | Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol. ( Friesinger, GC; Harston, WE, 1982) |
| "5 mg) and isosorbide dinitrate (ISDN, 30 mg slow release) was compared with placebo in sixteen patients with stable, exercise-induced angina pectoris." | 9.05 | Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris. ( Dorow, P; Schiess, W, 1984) |
| "The effects of the beta-adrenoceptor-blocking drugs propranolol, metoprolol, pindolol, and placebo, on mucociliary clearance were studied in three groups of 6 subjects with coronary heart disease and normal lung function." | 9.05 | Influence of propranolol, metoprolol, and pindolol on mucociliary clearance in patients with coronary heart disease. ( Dorow, P; Felix, R; Schiess, W; Schmutzler, H; Weiss, T, 1984) |
| "The effect of pindolol, a new beta-blocking agent, was evaluated in 12 patients with proven coronary disease (CAD) and angina pectoris." | 9.05 | Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris. ( Dwyer, EM; Pepe, AJ; Pinkernell, BH, 1982) |
| "A single blind randomized parallel study designed to assess the anti-anginal efficacy of pindolol and nifedipine was carried out in 42 ambulatory coronary patients with stable angina pectoris." | 9.04 | Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. ( Amrein, R; Castagnoli, E; Chu, D; Cocco, G; Strozzi, C, 1979) |
| "The effect of pindolol, a beta blocker with intrinsic sympathomimetic activity (ISA), on serum lipoprotein composition was studied in 13 patients admitted to the hospital for an attack of coronary heart disease." | 7.66 | Effect of pindolol on serum lipoproteins in patients with coronary heart disease. ( Karmakoski, J; Rönnemaa, T; Viikari, J, 1983) |
| "1 The study was designed to elucidate further the mechanism by which beta-adrenoceptor antagonism with pindolol relieves the symptoms of angina pectoris in patients with coronary heart disease." | 7.66 | The effect of pindolol on myocardial blood flow, metabolism and function during rest and pacing in patients with coronary heart disease. ( Bleifeld, W; Hamm, CW; Kupper, W, 1982) |
| "To determine whether the depression of left ventricular pumping activity associated with beta-blockade alone could be offset by a substantial degree of partial agonist activity, the haemodynamic dose-response effects of intravenous propranolol and pindolol were compared in a randomised between-group saline controlled study in twenty patients with angiographically proven coronary artery disease." | 6.65 | Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease. ( Ahuja, RC; Nelson, GI; Okoli, RC; Silke, B; Taylor, SH, 1983) |
| "10 patients (6 females and 4 males with an average age of 75 years) with stable angina pectoris were treated transdermally with mepindolol in a balanced, randomized, controlled, crossover study to compare the anti-ischemic effects of 12-hour overnight, and 24-hour applications." | 5.07 | Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application. ( Bonelli, J; Gazo, F; Kirsch, P; Liedtke, RK, 1991) |
| "A new transdermal beta-blocker containing system (Mepindolol BIO TSD) was compared in a placebo controlled cross over trial with a transdermal nitrate system in 14 patients suffering from coronary heart disease with stable angina pectoris." | 5.06 | [Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate]. ( Bonelli, J; Falkner, C; Gazo, F; Liedtke, RK, 1990) |
| "A new transdermal system (BIO TSD) containing the beta-adrenergic blocker mepindolol was assessed in a placebo controlled clinical trial in 12 patients with coronary heart disease." | 5.06 | [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris]. ( Bonelli, J; Gazo, F; Liedtke, RK, 1989) |
| "In a randomized, controlled study we found a significant decrease in pressure-rate (double) product and an improvement in exercise tolerance in patients with angina pectoris treated with pindolol." | 5.05 | Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol. ( Friesinger, GC; Harston, WE, 1982) |
| "5 mg) and isosorbide dinitrate (ISDN, 30 mg slow release) was compared with placebo in sixteen patients with stable, exercise-induced angina pectoris." | 5.05 | Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris. ( Dorow, P; Schiess, W, 1984) |
| "The effects of the beta-adrenoceptor-blocking drugs propranolol, metoprolol, pindolol, and placebo, on mucociliary clearance were studied in three groups of 6 subjects with coronary heart disease and normal lung function." | 5.05 | Influence of propranolol, metoprolol, and pindolol on mucociliary clearance in patients with coronary heart disease. ( Dorow, P; Felix, R; Schiess, W; Schmutzler, H; Weiss, T, 1984) |
| "The effect of pindolol, a new beta-blocking agent, was evaluated in 12 patients with proven coronary disease (CAD) and angina pectoris." | 5.05 | Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris. ( Dwyer, EM; Pepe, AJ; Pinkernell, BH, 1982) |
| "A single blind randomized parallel study designed to assess the anti-anginal efficacy of pindolol and nifedipine was carried out in 42 ambulatory coronary patients with stable angina pectoris." | 5.04 | Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. ( Amrein, R; Castagnoli, E; Chu, D; Cocco, G; Strozzi, C, 1979) |
| "Two grams of methylprednisolone was administratered to ten patients with acute myocardial infarction at an average of 13 hours from the onset of symptoms; pain in the chest was not relieved in six of the ten patients." | 5.04 | Failure of methylprednisolone to protect acutely ischemic myocardium: a contrast with subsequent beta-adrenergic blockade in man. ( Heikkilä, J; Nieminen, MS, 1978) |
| "Bopindolol is a nonselective beta-adrenoceptor antagonist [corrected] with partial agonist activity which is used in the treatment of hypertension." | 4.78 | Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. ( Goa, KL; Harron, DW; Langtry, HD, 1991) |
| "Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and bradycardia during combined therapy with verapamil and beta-adrenergic blocking drugs." | 3.66 | Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases. ( Anderson, ST; Federman, J; Harper, RW; Laufer, E; Pitt, A; Wayne, VS, 1982) |
| "The effect of pindolol, a beta blocker with intrinsic sympathomimetic activity (ISA), on serum lipoprotein composition was studied in 13 patients admitted to the hospital for an attack of coronary heart disease." | 3.66 | Effect of pindolol on serum lipoproteins in patients with coronary heart disease. ( Karmakoski, J; Rönnemaa, T; Viikari, J, 1983) |
| " Lidocaine and pindolol pretreatment increased the survival rate and attenuated the life-threatening arrhythmias during the first 20 min, but did not influence the infarct size 16 hrs later." | 3.66 | Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. ( Koltai, M; Leprán, I; Siegmund, W; Szekeres, L, 1983) |
| "1 The study was designed to elucidate further the mechanism by which beta-adrenoceptor antagonism with pindolol relieves the symptoms of angina pectoris in patients with coronary heart disease." | 3.66 | The effect of pindolol on myocardial blood flow, metabolism and function during rest and pacing in patients with coronary heart disease. ( Bleifeld, W; Hamm, CW; Kupper, W, 1982) |
| "Because coronary heart disease is known to have many causes, primary preventive therapy must logically go beyond the relatively simple goal of lowering blood pressure." | 2.66 | Effects of oral antihypertensive agents on blood lipid levels. ( Leren, P, 1986) |
| "To test the hypothesis that the depression of cardiac performance induced by competitive blockade of sympathetic stimulation at beta-adrenoceptors could be attenuated by the addition of a high level of intrinsic sympathomimetic activity (ISA) or concomitant alpha- and beta-blockade, the haemodynamic dose-response effects of propranolol (non-cardioselective, no ISA), pindolol (non-cardioselective, high ISA) and labetalol (non-cardioselective, alpha-blocker) were compared in a randomized study of 30 patients with stable coronary artery disease." | 2.65 | Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile. ( Ahuja, RC; Nelson, GI; Silke, B; Taylor, SH, 1983) |
| "To determine whether the depression of left ventricular pumping activity associated with beta-blockade alone could be offset by a substantial degree of partial agonist activity, the haemodynamic dose-response effects of intravenous propranolol and pindolol were compared in a randomised between-group saline controlled study in twenty patients with angiographically proven coronary artery disease." | 2.65 | Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease. ( Ahuja, RC; Nelson, GI; Okoli, RC; Silke, B; Taylor, SH, 1983) |
| "Bopindolol is a new beta blocker with a long duration of action." | 1.27 | Effects of bopindolol on left ventricular function during exercise in patients with coronary artery disease. ( Mérier, G; Ratib, O; Righetti, A; Rutishauser, W; Viquerat, C, 1986) |
| "Carazolol was active at considerably lower doses than pindolol (about 25 times less) and propranolol (about 100 times later)." | 1.26 | Comparative investigation on the cardio-protective action of the beta-blockers carazolol, propranolol and pindolol in rats. ( Bartsch, W; Dietmann, K; Kohler, M; Sponer, G, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 84 (90.32) | 18.7374 |
| 1990's | 9 (9.68) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johansson, SR | 1 |
| McCall, M | 1 |
| Wilhelmsson, C | 1 |
| Vedin, JA | 1 |
| Reiterer, W | 1 |
| Merker, R | 1 |
| Schwittek, W | 1 |
| Kladetzky, RG | 1 |
| Kuhn, H | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Bartsch, W | 1 |
| Sponer, G | 1 |
| Dietmann, K | 1 |
| Kohler, M | 1 |
| Bragina, GI | 2 |
| Heikkilä, J | 2 |
| Nieminen, MS | 3 |
| Gleichmann, U | 2 |
| Fassbender, D | 2 |
| Trieb, G | 2 |
| Mannebach, H | 1 |
| Ohlmeier, H | 1 |
| Harston, WE | 1 |
| Friesinger, GC | 1 |
| Wayne, VS | 1 |
| Harper, RW | 1 |
| Laufer, E | 1 |
| Federman, J | 1 |
| Anderson, ST | 1 |
| Pitt, A | 2 |
| Schuster, P | 1 |
| Nagai, S | 1 |
| Miyazaki, Y | 1 |
| Ogawa, K | 1 |
| Satake, T | 1 |
| Sugiyama, S | 1 |
| Ozawa, T | 2 |
| Frishman, WH | 2 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Silke, B | 3 |
| Nelson, GI | 2 |
| Ahuja, RC | 2 |
| Taylor, SH | 3 |
| Dorow, P | 3 |
| Schiess, W | 3 |
| Weiss, T | 2 |
| Felix, R | 2 |
| Schmutzler, H | 2 |
| Okoli, RC | 1 |
| Cherevatov, BG | 1 |
| Kucherenko, OD | 1 |
| Boiarshin, SV | 1 |
| Lorenz, D | 1 |
| Cocco, G | 2 |
| Strozzi, C | 2 |
| Chu, D | 2 |
| Amrein, R | 2 |
| Castagnoli, E | 2 |
| Dwyer, EM | 1 |
| Pepe, AJ | 1 |
| Pinkernell, BH | 1 |
| Karmakoski, J | 1 |
| Viikari, J | 1 |
| Rönnemaa, T | 1 |
| Leprán, I | 1 |
| Koltai, M | 1 |
| Siegmund, W | 1 |
| Szekeres, L | 2 |
| Jennings, G | 1 |
| Stirling, G | 1 |
| Korner, P | 1 |
| Kugler, G | 1 |
| Welzel, D | 1 |
| Kupper, W | 2 |
| Hamm, CW | 1 |
| Bleifeld, W | 2 |
| Stríz, S | 1 |
| Cagán, S | 1 |
| Kocinger, A | 1 |
| Iványi, J | 1 |
| Pocsai, G | 1 |
| Storstein, L | 1 |
| Spiel, R | 1 |
| Enenkel, W | 1 |
| Becker, HJ | 1 |
| Matthäus, EJ | 1 |
| Kaltenbach, M | 1 |
| Maksimova, LN | 1 |
| Sandomirskiĭ, BL | 1 |
| Giudicelli, JF | 1 |
| Berdeaux, A | 1 |
| Jullien, G | 1 |
| Tannenbaum, H | 1 |
| Komarov, FI | 2 |
| Ol'binskaia, LI | 1 |
| Bonelli, J | 6 |
| Magometschnigg, D | 3 |
| Schober, H | 1 |
| Kleinberger, G | 1 |
| Pichler, H | 1 |
| Kaik, G | 3 |
| Zilcher, H | 1 |
| Glogar, D | 1 |
| Kenedi, I | 1 |
| Wink, K | 1 |
| Tamura, K | 1 |
| Murooka, H | 1 |
| Hitzenberger, G | 2 |
| Hamm, C | 1 |
| Hanrath, P | 1 |
| Mathey, D | 1 |
| Oeff, M | 1 |
| Beck, OA | 1 |
| Hochrein, H | 1 |
| Kun, IS | 1 |
| Markova, VM | 1 |
| Mytareva, IL | 1 |
| Ostrovskaia, VI | 1 |
| Biffani, G | 1 |
| Santini, M | 1 |
| Flameng, W | 1 |
| Wüsten, B | 1 |
| Schaper, W | 1 |
| Meggs, LG | 1 |
| Huang, H | 1 |
| Li, P | 1 |
| Capasso, JM | 1 |
| Anversa, P | 1 |
| Liu, XK | 1 |
| Engelman, RM | 1 |
| Agrawal, HR | 1 |
| Das, DK | 1 |
| Harron, DW | 1 |
| Goa, KL | 1 |
| Langtry, HD | 1 |
| Gazo, F | 3 |
| Kirsch, P | 1 |
| Liedtke, RK | 3 |
| Falkner, C | 1 |
| Strasser, RH | 1 |
| Marquetant, R | 1 |
| Kübler, W | 1 |
| Khomenko, VL | 1 |
| Vasiuk, IuA | 1 |
| Romashkin, AV | 1 |
| Sivkov, SI | 1 |
| Mel'nikov, AIu | 1 |
| Buskin, VD | 1 |
| Rapola, JM | 1 |
| Pellinen, TJ | 1 |
| Toivonen, L | 1 |
| Kozlov, SG | 1 |
| Orekhov, AN | 1 |
| Tertov, VV | 1 |
| Liakishev, AA | 1 |
| Baldenkov, GN | 1 |
| Bocharova, OI | 1 |
| Ruda, MIa | 1 |
| Righetti, A | 1 |
| Mérier, G | 1 |
| Viquerat, C | 1 |
| Ratib, O | 1 |
| Rutishauser, W | 1 |
| Forfar, JC | 1 |
| Riemersma, RA | 1 |
| Russell, DC | 1 |
| Oliver, MF | 1 |
| Freissmuth, M | 1 |
| Schütz, W | 1 |
| Weindlmayer-Göttel, M | 1 |
| Zimpfer, M | 1 |
| Spiss, CK | 1 |
| Korkushko, OV | 1 |
| Shatilo, VB | 1 |
| Butenko, AG | 1 |
| Rousseau, MF | 1 |
| Pouleur, H | 1 |
| Debaisieux, JC | 1 |
| Van Eyll, C | 1 |
| Charlier, AA | 1 |
| Manfroi, WC | 1 |
| Vieira, SR | 1 |
| Koppe, VF | 1 |
| Goldin, JR | 1 |
| Freitas, FM | 1 |
| Faraco, EZ | 1 |
| Ribeiro, JP | 1 |
| Gebhardt, VA | 1 |
| Wisenberg, G | 1 |
| Svendsen, TL | 1 |
| Trap-Jensen, J | 1 |
| Carlsen, JE | 1 |
| McNair, A | 1 |
| Lepäntalo, M | 1 |
| Frais, MA | 1 |
| Verma, SP | 1 |
| Reynolds, G | 1 |
| Leren, P | 1 |
| Golf, S | 1 |
| Hansson, V | 1 |
| Harvengt, C | 1 |
| Desager, JP | 1 |
| Heller, F | 1 |
| Hulhoven, R | 1 |
| Grover, GJ | 1 |
| Weiss, HR | 1 |
| Kostis, JB | 1 |
| Li, JK | 1 |
| Kovacs, T | 1 |
| Kedem, J | 1 |
| Mérier, GR | 1 |
| Perrenoud, JJ | 1 |
| Turczyński, B | 1 |
| Znamirowska, D | 1 |
| Färber, A | 1 |
| Kraupp, O | 1 |
| Adamska-Dyniewska, H | 2 |
| Ohly, A | 1 |
| König, E | 1 |
| Nachreiner, K | 1 |
| Schmidt, F | 1 |
| Ducloux, M | 1 |
| Rosenfeld, JB | 1 |
| Traub, YM | 1 |
| Cohen, L | 1 |
| Schäcke, G | 1 |
| Bloedner, CD | 1 |
| Valentin, H | 1 |
| Ellner, O | 1 |
| Ziólkowski, L | 2 |
| Ilmurzyńska, K | 2 |
| Dunér, H | 1 |
| Pernow, B | 1 |
| Delius, L | 1 |
| Lübke, KO | 1 |
| Limbourg, P | 2 |
| Just, H | 2 |
| Lang, KF | 1 |
6 reviews available for pindolol and Coronary Disease
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activity.
Topics: Animals; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Child; Coronary Disease; Female; Human | 1983 |
[Long-term utilization of beta-blockers in arterial hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Coronary Disease; Drug Toleranc | 1978 |
Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Coronary Disease; Half-Life; Hemodyna | 1991 |
[Phrmacodynamic principles underlying the specific therapy of coronary vascular disease].
Topics: Adenosine; Adrenergic beta-Antagonists; Chemical Phenomena; Chemistry; Coronary Disease; Coronary Ve | 1973 |
33 trials available for pindolol and Coronary Disease
| Article | Year |
|---|---|
Duration of action of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Ra | 1980 |
[Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
Topics: Adrenergic beta-Antagonists; Coronary Disease; Drug Therapy, Combination; Fendiline; Hemodynamics; H | 1980 |
The influence of beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on local wall motion abnormalities in patients with coronary heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Cardiac Catheterization; Cineangiography; Coronary Disease; Fema | 1982 |
Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Diseas | 1982 |
[Influence of betablocking agents with and without intrinsic sympathicomimetic activity (ISA) on local wall-motion disorders in patients with coronary heart disease].
Topics: Adrenergic beta-Antagonists; Adult; Coronary Disease; Female; Heart; Hemodynamics; Humans; Male; Met | 1982 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
Topics: Adult; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Ethanolamines; | 1983 |
Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Met | 1984 |
Influence of propranolol, metoprolol, and pindolol on mucociliary clearance in patients with coronary heart disease.
Topics: Adult; Aged; Bronchi; Cilia; Coronary Disease; Female; Humans; Lung; Male; Metoprolol; Middle Aged; | 1984 |
Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.
Topics: Adult; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Female; Heart; Hemodynam | 1983 |
Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Fa | 1982 |
[Drug therapy of coronary heart disease with nitrisken retard].
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Drug Combinations; Female; Humans; Isos | 1982 |
[Duration of effect and dose-response relationship of a new beta-sympatholytic agent in comparison with pindolol in patients with coronary heart disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Dose-Response | 1976 |
[Ergometric study of the association of a beta-blocker and a nitrate derivative].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Clinical | 1978 |
[A double blind cross-over study with mepindolol-sulfate in patients with coronary heart disease (author's transl)].
Topics: Adrenergic beta-Antagonists; Aged; Coronary Disease; Double-Blind Method; Drug Evaluation; Female; H | 1979 |
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Hemodynamics; Humans; Male; Middle Aged; Nif | 1979 |
[Hemodynamics in patients with coronary heart disease under conditions of physical exercise before and after mepindolol-sulfate (author's transl)].
Topics: Aged; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardio | 1978 |
Failure of methylprednisolone to protect acutely ischemic myocardium: a contrast with subsequent beta-adrenergic blockade in man.
Topics: Acute Disease; Aged; Cardiac Output; Clinical Trials as Topic; Coronary Disease; Female; Humans; Inj | 1978 |
[Hemodynamic differences in the effects of mepindolol-sulfate and propranolol after 4 weeks treatment under conditions of rest and physical exercise in patients with coronary heart disease (author's transl)].
Topics: Aged; Blood Pressure; Coronary Disease; Depression, Chemical; Female; Heart Rate; Hemodynamics; Huma | 1978 |
Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Angina Pectoris; Blood Pressure; Coronary Diseas | 1991 |
[Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate].
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pecto | 1990 |
[Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Drug Evaluation; Female; Hemodynamics; Huma | 1990 |
Haemodynamic effects of bopindolol and atenolol in coronary artery disease. A noninvasive study.
Topics: Atenolol; Blood Pressure; Cardiac Output; Coronary Disease; Double-Blind Method; Echocardiography; H | 1990 |
[Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Disease; Ele | 1989 |
Improvement in wall motion after pindolol: a mechanism for the preservation of left ventricular function in coronary artery disease.
Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Cardiac Catheterization; Clinical Trials as Topic | 1989 |
Beta blockade and intermittent claudication.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Female; Gait; | 1985 |
Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Coronary Disease; Heart Rate; Hemodyna | 1986 |
Effects of oral antihypertensive agents on blood lipid levels.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Cl | 1986 |
[Ergometric evaluation of the cardioprotective effect of pindolol in coronary disease. Comparison of 2 galenic forms].
Topics: Adult; Blood Pressure; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; | 1988 |
Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
Topics: Blood Pressure; Clinical Trials as Topic; Clopamide; Coronary Disease; Drug Therapy, Combination; El | 1974 |
[Clinical studies on application of Visken in treatment of coronary disease (author's transl)].
Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Drug Evaluation; Female; Humans; Male; Midd | 1973 |
Haemodynamic effects of beta-receptor blocking agents and digitalis in ischaemic coronary heart disease with angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Brachial Artery; Cardiac Catheterization; Cardiac Output; Coronary | 1973 |
[The efficiency of coronary therapy with Visken (pindolol). A combined clinical and experimental analysis (author's transl)].
Topics: Adult; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Electrocardiogra | 1974 |
55 other studies available for pindolol and Coronary Disease
| Article | Year |
|---|---|
[Serum lipid levels under chronical treatment with beta-receptor blocking agents in patients with coronary artery disease (author's transl)].
Topics: Adrenergic beta-Antagonists; Alcohol Drinking; Cholesterol; Coronary Disease; Diabetes Mellitus; Hum | 1981 |
Comparative investigation on the cardio-protective action of the beta-blockers carazolol, propranolol and pindolol in rats.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Glycogen; Heart Diseases; Isoproterenol; Mem | 1981 |
[Effectiveness of the combined use of adrenergic beta receptor blockaders and long-acting nitrates in chronic ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Chronic Disease; Coronary Disease; Delayed-Action Preparat | 1981 |
Acute myocardial infarction: selective or ISA-type beta-adrenoceptor blocking drug?
Topics: Adrenergic beta-Antagonists; Coronary Disease; Humans; Metoprolol; Myocardial Infarction; Pindolol; | 1982 |
Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases.
Topics: Adrenergic beta-Antagonists; Aged; Bradycardia; Coronary Disease; Drug Interactions; Drug Therapy, C | 1982 |
The effects of beta-blocking agents on mitochondrial function in ischemic myocardium.
Topics: Acebutolol; Acyl Coenzyme A; Adrenergic beta-Antagonists; Animals; Coronary Disease; Dogs; Female; I | 1984 |
[Effect of visken and cordarone on myocardial function in patients with ischemic heart disease].
Topics: Adult; Amiodarone; Benzofurans; Coronary Disease; Drug Therapy, Combination; Female; Hemodynamics; H | 1983 |
[Human pharmacology of carteolol].
Topics: Administration, Oral; Blood Platelets; Carteolol; Coronary Disease; Hemodynamics; Humans; Hypertensi | 1983 |
The influence of propranolol, metoprolol, and mepindolol on mucociliary clearance in coronary heart disease patients without pulmonary disease.
Topics: Cilia; Coronary Disease; Female; Humans; Lung; Lung Diseases; Male; Metoprolol; Middle Aged; Mucous | 1984 |
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Humans; Male; Middle Aged; Nifedipine; Pindo | 1980 |
Effect of pindolol on serum lipoproteins in patients with coronary heart disease.
Topics: Cholesterol; Cholesterol, HDL; Coronary Disease; Female; Humans; Lipoproteins; Lipoproteins, HDL; Ma | 1983 |
Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Coronary Vessels; Disease Models, Animal; Lidocaine | 1983 |
Effects of beta blockade on work--delta ST segment curves during exercise, and relation to subsequent results of coronary artery bypass surgery.
Topics: Coronary Artery Bypass; Coronary Disease; Electrocardiography; Exercise Test; Heart; Humans; Pindolo | 1980 |
The effect of pindolol on myocardial blood flow, metabolism and function during rest and pacing in patients with coronary heart disease.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Cerebrovascular Circulation; Coronary Circulation; Coronary | 1982 |
[Polygraphic examination of patients with ischemic heart disease after administration of Viskenit 45 (author's transl)].
Topics: Adult; Aged; Coronary Disease; Drug Combinations; Female; Hemodynamics; Humans; Isosorbide Dinitrate | 1981 |
Experiences in patients treated with Visken.
Topics: Adolescent; Adult; Aged; Coronary Disease; Female; Humans; Male; Middle Aged; Pindolol | 1980 |
Delay of onset of second degree pacemaker block by beta-blockade in patients with P-synchronous pacemakers.
Topics: Adult; Aged; Alprenolol; Coronary Disease; Exercise Test; Female; Heart Rate; Humans; Male; Middle A | 1981 |
[Effect of Fendilin on the exercise test in patients with coronary disease].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Coronary Disease; Electrocardiography; Exercise Test; F | 1976 |
[Effect of adrenergic beta receptor blockaders on bronchial patency in ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Bronchi; Bronchial Spasm; Coronary Disease; Humans; Oxprenolol; Pindolo | 1978 |
[Beta-blockers: redistribution of coronary blood flow and experimental myocardial ischaemia].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Circulation; Coronary Disease; Disease Mode | 1978 |
[Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Coronary Disease; Echocardiography; Female; Hemodynamics; | 1979 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
[Diagnostic importance of visken -- an adrenergic beta receptor blocking agent].
Topics: Adolescent; Adult; Cardiac Complexes, Premature; Coronary Disease; Electrocardiography; Female; Hear | 1975 |
[Treatment of coronary insufficiency with beta receptor blocking agents].
Topics: Adrenergic beta-Antagonists; Adult; Chemical Phenomena; Chemistry; Coronary Disease; Heart; Humans; | 1975 |
"Near maximal" exercise test by treadmill for evaluation of cardiac function.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Blood Pressure; Coronary Artery Bypass; Coronary Circulat | 1979 |
[Effect of pindolol on myocardial blood supply, metabolism and function at rest and under frequency stimulation in patients with coronary disease].
Topics: Adult; Aged; Coronary Disease; Coronary Vessels; Hemodynamics; Humans; Middle Aged; Oxygen Consumpti | 1978 |
[Influence of digitalis on pindolol activity in exercise-induced cardiac failure in patients with coronary disease (author's transl)].
Topics: Acetyldigoxins; Aged; Blood Pressure; Capillaries; Coronary Disease; Digoxin; Drug Interactions; Fem | 1979 |
[Experience in using visken in ischemic heart disease and arterial hypertension].
Topics: Adult; Aged; Coronary Disease; Humans; Hypertension; Middle Aged; Pindolol | 1977 |
[Hemodynamic evaluation of pindolol].
Topics: Adolescent; Adult; Blood Pressure; Cardiac Output; Coronary Disease; Drug Evaluation; Heart Rate; He | 1976 |
Effects of prindolol on isoproterenol-induced subendocardial ischaemia in dogs with multiple chronic coronary artery occlusion.
Topics: Animals; Collateral Circulation; Coronary Angiography; Coronary Disease; Coronary Vessels; Dipyridam | 1975 |
Chronic nonocclusive coronary artery constriction in rats. Beta-adrenoceptor signal transduction and ventricular failure.
Topics: Adenylyl Cyclases; Alkaline Phosphatase; Animals; Coronary Disease; GTP-Binding Proteins; Hemodynami | 1991 |
Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Coronary Disease; Creatine Kinase; Fatty | 1991 |
Independent sensitization of beta-adrenoceptors and adenylate cyclase in acute myocardial ischaemia.
Topics: Acute Disease; Adenine Nucleotides; Adenosine Triphosphate; Adenylyl Cyclases; Adrenergic beta-Agoni | 1990 |
[Effects of beta adrenergic blocking agents and calcium antagonists on atherogenic properties of blood serum of patients with ischemic heart disease].
Topics: Adult; Cells, Cultured; Coronary Disease; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Nifed | 1990 |
Effects of bopindolol on left ventricular function during exercise in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Coronary Disease; Heart; Heart Rate; Heart Ventr | 1986 |
Effect of pindolol on neurosympathetic responsiveness, blood flow variability, and conduction in acutely ischaemic myocardium: the importance of heart rate.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Catecholamines; Coronary Circulation; Coronary Dise | 1987 |
Effects of ischemia on the canine myocardial beta-adrenoceptor-linked adenylate cyclase system.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Coronary Disease; Dog | 1987 |
[Effectiveness of tobanum and visken in ischemic heart disease with extrasystole].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiac Complexes, Premature; Coronary Disease | 1989 |
Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.
Topics: Adrenergic beta-Agonists; Blood Pressure; Coronary Disease; Diastole; Female; Heart; Heart Rate; Hum | 1989 |
The role of beta blockade, with and without intrinsic sympathomimetic activity, in preserving compromised left ventricular function in patients with ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Echocar | 1985 |
Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Output; Coronary Disease; Heart Rat | 1985 |
Effects of beta blocking agents on the density of beta adrenoceptors and adenylate cyclase response in human myocardium: intrinsic sympathomimetic activity favours receptor upregulation.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Coronary Disease; Heart; Humans; Isoproterenol; Myoc | 1986 |
Beta-blocking agents and plasma lipids: an update.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hyper | 1987 |
Beta-adrenoceptor stimulation and blockade during myocardial ischemia in dogs: effect on cardiac O2 supply and consumption.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Gas Analysis; Coronary Circula | 1987 |
Cardioprotection by anti-ischaemic and cytoprotective drugs.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden; Dietary Fats; Epoprostenol; Humans; | 1987 |
[Effect of adrenergic beta receptor blockaders on blood viscosity after their short-term use in patients with arteriosclerosis].
Topics: Adult; Aged; Blood Viscosity; Coronary Disease; Humans; Middle Aged; Pindolol; Propranolol; Time Fac | 1985 |
[Treatment of tachycardias and arrhythmias. Studies using Visken].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Coronary Di | 1974 |
[Comparison of the effects of propranolol, practolol, oxyprenolol and L.B. 46 on myocardial contractility].
Topics: Acetanilides; Adrenergic beta-Antagonists; Adult; Amino Alcohols; Arteriosclerosis; Coronary Disease | 1973 |
[Cardiodepressive side effects of beta sympatholytic therapy. Clinical tests with Visken].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Coronary Disease; Dose-Response Rela | 1973 |
[Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Coronary Disease; Exercise Test; Heart; H | 1973 |
[Pindolol in foreign medical practice].
Topics: Adrenergic beta-Antagonists; Adult; Africa, Northern; Angina Pectoris; Arrhythmias, Cardiac; Arterio | 1973 |
[Preventive, long-term studies of ECG and heart rate using radiotelemetry during beta sympatholysis].
Topics: Adrenergic beta-Antagonists; Age Factors; Blood Pressure; Cardiovascular Diseases; Coronary Disease; | 1972 |
[Contraction and output capacity of the heart with coronary disease during beta adrenolysis using LB 46 (visken)].
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Disease; Electrocardiography; Heart | 1972 |
[Results of Visken treatment of severe cases of coronary disease].
Topics: Adult; Aged; Coronary Disease; Drug Evaluation; Female; Humans; Male; Middle Aged; Pindolol | 1973 |
[Comparative studies on practolol, pindolol and propranolol effect on hemodynamics and contractility of left ventricle in coronary disease patients].
Topics: Coronary Disease; Heart; Heart Ventricles; Hemodynamics; Humans; Muscle Contraction; Pindolol; Pract | 1973 |